» Articles » PMID: 28713997

The Biological Functions and Mechanism of MiR‑212 in Prostate Cancer Proliferation, Migration and Invasion Via Targeting Engrailed-2

Overview
Journal Oncol Rep
Specialty Oncology
Date 2017 Jul 18
PMID 28713997
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulating evidence indicates that Engrailed-2 (EN-2), which is a homeobox-containing transcription factor, act as a candidate oncogene in prostate cancer (PCa). Even though there are some treatments targeting EN-2, however, it is limited because the mechanism of EN-2 upregulation in PCa cells is still unknown. In this study, we investigate the role of miR‑212 on EN-2 expression and explored the mechanism of prostate cancer survival and metastasis. The relative expression levels of miR‑212 and EN-2 in PCa samples and adjacent normal tissues as well as in PCa cell lines were detected by using quantitative real-time PCR. CCK-8, TUNEL and Transwell assays were used to analyze cell proliferation, apoptosis and invasion, respectively. EN-2 was identified as a direct target of miR‑212 via luciferase reporter and western blot assays. Results showed that the expression level of miR‑212 was downregulated in both PCa samples and PCa cell lines when compared with prostate epithelial cells and the adjacent no tumor tissues. Moreover, we found that overexpression of miR‑212 suppressed PCa cell proliferation and invasion, promoted PCa cell apoptosis. EN-2 was identified as a direct target gene of miR‑212 by using luciferase reporter and western blot assays. Also, the expression of EN-2 and miR‑212 in the PCa cells had an opposite correlation. The critical role of miR‑212 in inhibiting prostate tumor growth was verified in xenograft models of prostate cancer. These findings highlighted the role of miR‑212 in PCa progression. More importantly, we speculate that EN-2 is a direct target gene of miR‑212.

Citing Articles

Tirzepatide prevents neurodegeneration through multiple molecular pathways.

Fontanella R, Ghosh P, Pesapane A, Taktaz F, Puocci A, Franzese M J Transl Med. 2024; 22(1):114.

PMID: 38287296 PMC: 10823712. DOI: 10.1186/s12967-024-04927-z.


MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2.

Song B, Xu L, Jiang K, Cheng F Funct Integr Genomics. 2023; 23(2):80.

PMID: 36884182 PMC: 9995421. DOI: 10.1007/s10142-023-00991-8.


An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22.

Centomo M, Vitiello M, Poliseno L, Pandolfi P Cancers (Basel). 2022; 14(24).

PMID: 36551740 PMC: 9776418. DOI: 10.3390/cancers14246255.


Role of germline variants in the metastasis of breast carcinomas.

Santonja A, Moya-Garcia A, Ribelles N, Jimenez-Rodriguez B, Pajares B, Fernandez-De Sousa C Oncotarget. 2022; 13:843-862.

PMID: 35782051 PMC: 9245581. DOI: 10.18632/oncotarget.28250.


MiR-212 value in prognosis and diagnosis of cancer and its association with patient characteristics: a systematic review and meta-analysis.

Raji S, Sahranavard M, Mottaghi M, Sahebkar A Cancer Cell Int. 2022; 22(1):163.

PMID: 35473623 PMC: 9044851. DOI: 10.1186/s12935-022-02584-0.


References
1.
Marszall M, Sroka W, Adamowski M, Slupski P, Jarzemski P, Siodmiak J . Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination. Eur J Cancer Prev. 2014; 24(1):51-6. DOI: 10.1097/CEJ.0000000000000046. View

2.
Steinfeld I, Navon R, Ach R, Yakhini Z . miRNA target enrichment analysis reveals directly active miRNAs in health and disease. Nucleic Acids Res. 2012; 41(3):e45. PMC: 3561970. DOI: 10.1093/nar/gks1142. View

3.
Schetter A, Leung S, Sohn J, Zanetti K, Bowman E, Yanaihara N . MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008; 299(4):425-36. PMC: 2614237. DOI: 10.1001/jama.299.4.425. View

4.
Li Y, Liu H, Lai C, Su Z, Heng B, Gao S . Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo. Oncol Rep. 2015; 33(5):2319-30. DOI: 10.3892/or.2015.3858. View

5.
Van Kouwenhove M, Kedde M, Agami R . MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011; 11(9):644-56. DOI: 10.1038/nrc3107. View